Contribution of NMDA and non-NMDA receptors to in vivo glutamate-induced calpain activation in the rat striatum. Relation to neuronal damage

Neurochemical Research

Volumn 33, Issue 8, 2008, Pages 1475-1483

  Del Río, Perla ^a   Montiel, Teresa ^a   Massieu, Lourdes ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

AMPA; Calpain; Caspase 3; Kainate; Neurotoxicity; NMDA

Indexed keywords

AMPA RECEPTOR; CALCIUM; CALPAIN; CASPASE 3; FODRIN; GLUTAMIC ACID; IONOTROPIC RECEPTOR; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; ENZYME ACTIVITY; EXCITOTOXICITY; MALE; NERVE CELL LESION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

ANIMALS; CALPAIN; CASPASE 3; CORPUS STRIATUM; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; DIZOCILPINE MALEATE; ENZYME ACTIVATION; EXCITATORY AMINO ACID ANTAGONISTS; MALE; NEURONS; NEUROPROTECTIVE AGENTS; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; SPECTRIN;

RATTUS;

EID: 46249101510     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-008-9612-1     Document Type: Article

References (54)

1. Olney JW, Ho OL, Rhee V (1971) Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp Brain Res 14:61-76
2. Choi DW, Koh JY, Peters S (1988) Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci 8:185-196
3. Koh JY, Goldberg MP, Hartley DM, Choi DW (1990) Non-NMDA receptor-mediated neurotoxicity in cortical culture. J Neurosci 10:693-705
4. Choi DW (1987) Ionic dependence of glutamate neurotoxicity. J Neurosci 7:369-379
5. Randall RD, Thayer SA (1992) Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. J Neurosci 12:1882-1895
6. Michaels RL, Rothman SM (1990) Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. J Neurosci 10:283-292
7. Lafon-Cazal M, Culcasi M, Gaven F et al (1993) Nitric oxide, superoxide and peroxynitrite: putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology 32:1259-1266
8. Mattson MP (2007) Calcium and neurodegeneration. Aging Cell 6:337-350
9. Oliver MW, Baudry M, Lynch G (1989) The protease inhibitor leupeptin interferes with the development of LTP in hippocampal slices. Brain Res 505:233-238
10. del Cerro S, Larson J, Oliver MW et al (1990) Development of hippocampal long-term potentiation is reduced by recently introduced calpain inhibitors. Brain Res 530:91-95
11. Denny JB, Polan-Curtain J, Ghuman A et al (1990) Calpain inhibitors block long-term potentiation. Brain Res 534:317-320
12. Vanderklish P, Bednarski E, Lynch G (1996) Translational suppression of calpain blocks long-term potentiation. Learn Mem 3:209-217
13. Wang K (2000) Calpain and caspase: can you tell the difference? Trends Neurosci 23:20-26
14. Goll D, Thompson V, Li H et al (2002) The calpain system. Physiol Rev 83:731-801
15. Seubert P, Lee K, Lynch G (1989) Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus. Brain Res 492:366-370
16. Lee KS, Frank S, Vanderklish P et al (1991) Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci USA 88:7233-7237
17. Rami A, Krieglstein J (1993) Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo. Brain Res 609:67-70
18. Siman R, Noszek JC (1988) Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1:279-287
19. Bahr BA, Tiriveedhi S, Park GY et al (1995) Induction of calpain-mediated spectrin fragments by pathogenic treatments in long-term hippocampal slices. J Pharmacol Exp Ther 273:902-908
20. Aráujo IM, Verdasca MJ, Leal EC et al (2004) Early calpain-mediated proteolysis following AMPA receptor activation compromises neuronal survival in cultured hippocampal neurons. J Neurochem 91:1322-1331
21. MacDermott AB, Mayer ML, Westbrook GL et al (1986) NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature 321:519-522
22. Mayer ML, Westbrook GL (1987) Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurons. J Physiol 394:501-527
23. Markgraf CG, Velayo NL, Johnson MP et al (1998) Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats. Stroke 29:152-158
24. Ankarcrona M, Dypbukt JM, Bonfoco E et al (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15:961-973
25. Bonfoco E, Krainc D, Ankarcrona M et al (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92:7162-7166
26. Cheung NS, Pascoe CJ, Giardina SF et al (1998) Micromolar L-glutamate induces extensive apoptosis in an apoptotic-necrotic continuum of insult-dependent, excitotoxic injury in cultured cortical neurons. Neuropharmacology 37:1419-1429
27. Siman R, Noszek JC, Kegerise C (1989) Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci 9:1579-1590
28. Del Rio P, Montiel T, Chagoya V et al (2007) Exacerbation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: relation to energy imbalance or ATP depletion? Neuroscience 146:1561-1570
29. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, Sidney
30. Massieu L, Moran J, Christen Y (2004) Effect of Ginkgo biloba (EGb 761) on staurosporine-induced neuronal death and caspase activity in cortical cultured neurons. Brain Res 1002:76-85
31. Bahr BA, Tiriveedhi S, Park GY et al (1995) Induction of calpain-mediated spectrin fragments by pathogenic treatments in long-term hippocampal slices. J Pharmacol Exp Ther 273:902-908
32. Roberts-Lewis JM, Siman R (1993) Spectrin proteolysis in the hippocampus: a biochemical marker for neuronal injury and neuroprotection. Ann N Y Acad Sci 679:78-86
33. Roberts-Lewis JM, Savage MJ, Marcy VR et al (1994) Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J Neurosci 14:3934-3944
34. Bizat N, Hermel JM, Boyer F et al (2003) Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease. J Neurosci 23:5020-5030
35. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
36. Massieu L, Tapia R (1994) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo[f] quinoxaline protects against both AMPA and kainate-induced lesions in the rat striatum in vivo. Neuroscience 59:931-938
37. Massieu L, Del Rio P, Montiel T (2001) Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates. Neuroscience 106:669-677
38. Montiel T, Camacho A, Estrada-Sanchez AM et al (2005) Differential effects of the substrate inhibitor L-trans-pyrrolidine-2,4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) of glutamate transporters on neuronal damage and extracellular amino acid levels in rat brain in vivo. Neuroscience 133:667-678
39. Camacho A, Montiel T, Massieu L (2006) The anion channel blocker, 4,4'-dinitrostilbene-2,2'-disulfonic acid prevents neuronal death and excitatory amino acid release during glycolysis inhibition in the hippocampus in vivo. Neuroscience 142:1005-1017
40. Siman R, Noszek JC, Kegerise C (1989) Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage. J Neurosci 9:1579-1590
41. Bahr BA, Tiriveedhi S, Park GY et al (1995) Induction of calpain-mediated spectrin fragments by pathogenic treatments in long-term hippocampal slices. J Pharmacol Exp Ther 273:902-908
42. Jourdi H, Yanagihara T, Martinez U et al (2005) Effects of positive AMPA receptor modulators on calpain-mediated spectrin degradation in cultured hippocampal slices. Neurochem Int 46:31-40
43. Lopez-Picon FR, Kukko-Lukjanov TK, Holopainen IE (2006) The calpain inhibitor MDL-28170 and the AMPA/KA receptor antagonist CNQX inhibit neurofilament degradation and enhance neuronal survival in kainic acid-treated hippocampal slice cultures. Eur J Neurosci 23:2686-2694
44. Mejia-Toiber J, Montiel T, Massieu L (2006) D-beta-hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo. Neurochem Res 31:1399-1408
45. Sanchez-Carbente MR, Massieu L (1999) Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired. J Neurochem 72:129-138
46. Greene JG, Greenamyre JT (1995) Exacerbation of NMDA, AMPA and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate. J Neurochem 64:2332-2338
47. Vanderklish PW, Bahr BA (2000) The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol 81:323-339
48. Czogalla A, Sikorski AF (2005) Spectrin and calpain: a 'target' and a 'sniper' in the pathology of neuronal cells. Cell Mol Life Sci 62:1913-1924
49. i changes in cultured rat hippocampal neurons. Eur J Neurosci 12:2021-2031
50. 2+ exchanger in excitotoxicity. Cell 120:275-285
51. 2+ pump activity in rat hippocampal neurons. J Neurochem 98:1646-1656
52. Yuen EY, Gu Z, Yan Z (2007) Calpain regulation of AMPA receptor channels in cortical piramidal neurons. J Physiol 580:241-254
53. Li P-A, Howlett W, He QP (1998) Postischemic treatment with calpain inhibitor MDL 28170 ameliorates brain damage in a gerbil model of global ischemia. Neurosci Lett 247:17-20
54. Ozawa S, Kamiya H, Tsuzuki K (1998) Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 54:581-618